Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leniolisib in APDS/PASLI
2014-003876-22Phase 2
- Sponsor
- Novartis
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of leniolisib in Activated PI3Kδ syndrome (APDS) (3 arms), sponsored by Novartis.
02
Drugs
leniolisib
03
Conditions
Activated PI3Kδ syndrome (APDS)
Beyond the preview
Go deeper on 2014-003876-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003876-22.